Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalopathy, Hepatocerebral”

246 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 246 results

Not applicableStudy completedNCT06384443
What this trial is testing

Proton Pump Inhibitors in Cirrhotic Patients

Who this might be right for
Proton Pump Inhibitor Adverse ReactionLiver Cirrhosis
National Liver Institute, Egypt 1,000
Not applicableStudy completedNCT00533910
What this trial is testing

Rifaximin in Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Hunter Holmes Mcguire Veteran Affairs Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50
Post-approval studies (Phase 4)UnknownNCT05920213
What this trial is testing

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy Stage 2Hepatic Encephalopathy Stage 3Hepatic Encephalopathy Stage 4
Jinnah Postgraduate Medical Centre 360
Large-scale testing (Phase 3)Study completedNCT02016196
What this trial is testing

Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS

Who this might be right for
Cirrhosis
University Hospital, Toulouse 211
Post-approval studies (Phase 4)UnknownNCT05788627
What this trial is testing

Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyChronic Liver Disease
Khyber Medical College, Peshawar 100
Not applicableStudy completedNCT02613858
What this trial is testing

Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan

Who this might be right for
Hepatic Encephalopathy
Abbott 550
Not applicableNot Yet RecruitingNCT07272707
What this trial is testing

Psychometric Hepatic Encephalopathy Score in Prediction of Minimal Hepatic Encephalopathy in Compensated Cirrhotic Patients

Who this might be right for
Minimal Hepatic Encephalopathy
Sohag University 150
Large-scale testing (Phase 3)Study completedNCT06478602
What this trial is testing

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Cristian Ichim 19
Testing effectiveness (Phase 2)UnknownNCT00281502
What this trial is testing

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHepatitis CLiver Cirrhosis
Weill Medical College of Cornell University 50
Not applicableLooking for participantsNCT06953921
What this trial is testing

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

Who this might be right for
Hepatic Encephalopathy
Sohag University 100
Not applicableNot Yet RecruitingNCT07150195
What this trial is testing

Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)

Who this might be right for
Cirrhoses, LiverHepatic Encephalopathy (HE)
The First Affiliated Hospital with Nanjing Medical University 32
Early research (Phase 1)Study completedNCT00986895
What this trial is testing

Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Who this might be right for
Hepatic EncephalopathyUrea Cycle Disorders
Amgen 32
Not applicableUnknownNCT03306498
What this trial is testing

Plasma Free Amino Acids in Patients With Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Assiut University 100
Not applicableStudy completedNCT01494064
What this trial is testing

Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Assistance Publique - Hôpitaux de Paris 224
Not applicableStudy completedNCT00424957
What this trial is testing

Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System

Who this might be right for
CirrhosisHepatic Encephalopathy
University of Aarhus 18
Large-scale testing (Phase 3)UnknownNCT00553423
What this trial is testing

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

Who this might be right for
Hepatocerebral EncephalopathyPortal-Systemic EncephalopathyEncephalopathy, Hepatic+1 more
Aga Khan University 128
Not applicableUnknownNCT04317222
What this trial is testing

Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE

Who this might be right for
Acute-On-Chronic Liver FailureHepatic Encephalopathy
Third Affiliated Hospital, Sun Yat-Sen University 250
Not applicableUnknownNCT01597102
What this trial is testing

Cerebrovascular Autoregulation During and After Liver Transplantation

Who this might be right for
Encephalopathy, HepaticCerebrovascular DisordersLiver Failure
Johannes Gutenberg University Mainz 20
Post-approval studies (Phase 4)Study completedNCT00955500
What this trial is testing

Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Hospital Universitari Vall d'Hebron Research Institute 116
Next Page